CareTrust REIT (CTRE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2025, CareTrust REIT (CTRE) reported revenue of $112.47 million, up 63.3% over the same period last year. EPS came in at $0.43, compared to $0.07 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $107.52 million, representing a surprise of +4.6%. The company delivered an EPS surprise of -4.44%, with the consensus EPS estimate being $0.45.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how CareTrust REIT performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenues- Rental income: $86.03 million versus $75.75 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +55.3% change.Revenues- Interest income from other real estate related investments and other income: $23.55 million versus $25.05 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +74.7% change.Net Earnings Per Share (Diluted): $0.35 compared to the $0.36 average estimate based on two analysts.View all Key Company Metrics for CareTrust REIT here>>>Shares of CareTrust REIT have returned +6% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CareTrust REIT, Inc. (CTRE): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks